Home Cart Sign in  
Chemical Structure| 22560-50-5 Chemical Structure| 22560-50-5

Structure of Clodronic acid disodium salt
CAS No.: 22560-50-5

Chemical Structure| 22560-50-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Clodronate Disodium is an anti-osteoporotic drug.

Synonyms: Clodronate Disodium; Clodronate disodium salt

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Clodronic acid disodium salt

CAS No. :22560-50-5
Formula : CH2Cl2Na2O6P2
M.W : 288.86
SMILES Code : ClC(P([O-])([O-])=O)(P(O)(O)=O)Cl.[Na+].[Na+]
Synonyms :
Clodronate Disodium; Clodronate disodium salt
MDL No. :MFCD01632786

Safety of Clodronic acid disodium salt

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H319-H372-H410
Precautionary Statements:P501-P273-P260-P270-P264-P280-P391-P314-P337+P313-P305+P351+P338-P301+P312+P330
Class:9
UN#:3077
Packing Group:

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00873808 - Withdrawn(lack of accrual) - United States, Washington ... More >> University Cancer Center at University of Washington Medical Center Seattle, Washington, United States, 98195-6043 Less <<
NCT00216060 Metastatic Prostate Cancer Phase 3 Terminated(Terminated due to l... More >>ow accrual) Less << - -
NCT00658268 Aseptic Loosening of the Hip P... More >>rosthesis Less << Phase 2 Completed - Sweden ... More >> Lund University Hospital Lund, Sweden, SE-22185 Less <<
NCT00216060 - Terminated(Terminated due to l... More >>ow accrual) Less << - -
NCT00003232 Pain Prostate... More >> Cancer Quality of Life Less << Phase 3 Completed - Canada, Alberta ... More >> Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada, T2N 4N2 Canada, British Columbia Penticton Regional Hospital Penticton, British Columbia, Canada, V2A 3G6 British Columbia Cancer Agency - Fraser Valley Cancer Centre Surrey, British Columbia, Canada, V3V 1Z2 B.C. Cancer Agency Vancouver, British Columbia, Canada, V5Z 4E6 Canada, New Brunswick Saint John Regional Hospital Saint John, New Brunswick, Canada, E2L 4L2 Canada, Newfoundland and Labrador Newfoundland Cancer Treatment and Research Foundation St. Johns, Newfoundland and Labrador, Canada, A1B 3V6 Canada, Nova Scotia Nova Scotia Cancer Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Kingston Regional Cancer Centre Kingston, Ontario, Canada, K7L 5P9 Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Trillium Health Centre Mississauga, Ontario, Canada, L5B 1B8 Ottawa Regional Cancer Center - General Division Ottawa, Ontario, Canada, K1H 8L6 Peterborough Oncology Clinic Peterborough, Ontario, Canada, K9H 7B6 Hotel Dieu Hospital - St. Catharines St. Catharines, Ontario, Canada, L2R 5K3 Northwestern Ontario Regional Cancer Centre, Thunder Bay Thunder Bay, Ontario, Canada, P7A 7T1 Toronto Sunnybrook Regional Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Humber River Regional Hospital Weston, Ontario, Canada, M9N 1N8 Cancer Care Ontario - Windsor Regional Cancer Centre Windsor, Ontario, Canada, N8W 2X3 Canada, Prince Edward Island Queen Elizabeth Hospital, PEI Charlottetown, Prince Edward Island, Canada, C1A 8T5 Canada, Quebec McGill University Department of Oncology Montreal, Quebec, Canada, H2W 1S6 Less <<
NCT01348243 Postmenopausal Osteoporosis Phase 3 Completed - Italy ... More >> Policlinico GB Rossi Verona, Italy Less <<
NCT00127205 Breast Cancer Phase 3 Active, not recruiting May 2020 -
NCT00009945 Breast Cancer Phase 3 Completed - United States, Arizona ... More >> CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Florida Mayo Clinic Jacksonville, Florida, United States, 32224 United States, Hawaii MBCCOP - Hawaii Honolulu, Hawaii, United States, 96813 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Mississippi Veterans Affairs Medical Center - Biloxi Biloxi, Mississippi, United States, 39531-2410 United States, North Dakota Medcenter One Health System Bismarck, North Dakota, United States, 58501-5505 Altru Cancer Center Grand Forks, North Dakota, United States, 58201 United States, Pennsylvania CCOP - Geisinger Clinic and Medical Center Danville, Pennsylvania, United States, 17822-2001 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 United States, Tennessee University of Tennessee Cancer Institute Memphis, Tennessee, United States, 38103 Danville Radiation Therapy Center Memphis, Tennessee, United States, 38104 United States, Texas Harrington Cancer Center Amarillo, Texas, United States, 79106 Veterans Affairs Medical Center - Amarillo Amarillo, Texas, United States, 79106 United States, Vermont Fletcher Allen Health Care - University Health Center Campus Burlington, Vermont, United States, 05401 United States, Virginia MBCCOP - Massey Cancer Center Richmond, Virginia, United States, 23298-0037 United States, Washington University of Washington School of Medicine Seattle, Washington, United States, 98109 Less <<
NCT00009945 - Completed - -
NCT01291433 Radiation Induced Brachial Ple... More >>xopathy Less << Phase 3 Completed - France ... More >> Groupe Hospitalier Pitié-Salpêtrière Paris, France Hôpital Saint-Louis Paris, France Less <<
NCT01198457 - Completed - Czech Republic ... More >> Many Locations, Czech Republic Less <<
NCT00877097 Osteoporosis Not Applicable Completed - -
NCT00909142 - Completed - Czech Republic ... More >> Many locations, Czech Republic Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.46mL

0.69mL

0.35mL

17.31mL

3.46mL

1.73mL

34.62mL

6.92mL

3.46mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories